States / South Dakota / HB 1169
HB 1169 Enacted
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Mar 9, 2026 · Office of the Governor
Signed by the Governor on 2026-03-09 H.J. 534
Mar 4, 2026 · Senate
Delivered to the Governor on 2026-03-04 H.J. 497
Mar 3, 2026 · Senate
Signed by the President S.J. 448
Mar 2, 2026 · Senate
Signed by the Speaker H.J. 477
Feb 26, 2026 · Senate
Senate Do Pass , Passed, YEAS 32, NAYS 0 S.J. 412
Feb 25, 2026 · Senate
Scheduled for hearing S.J. 1
Feb 25, 2026 · Senate
Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0 S.J. 21
Feb 25, 2026 · Senate
Certified uncontested, placed on consent , Passed, S.J. 21
Feb 12, 2026 · Senate
First read in Senate and referred to Senate Health and Human Services S.J. 260
Feb 11, 2026 · House
House of Representatives Do Pass , Passed, YEAS 63, NAYS 3 H.J. 295
Feb 10, 2026 · House
Scheduled for hearing
Feb 10, 2026 · House
Health and Human Services Do Pass , Passed, YEAS 11, NAYS 0
Feb 10, 2026 · House
Certified uncontested, placed on consent , Passed,
Jan 28, 2026 · House
First read in House and referred to House Health and Human Services H.J. 163